Patiromer

Records for this ingredient, by country (identity only).

ATC V03AE09 · 4 markets · 11 records

Patiromer 4 markets · 11 records Forms
Filters
Kind

US 4 records · 4 shown of 4 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

AU 3 records · 2 shown of 2 Source PBS Schedule API v3 (Department of、TGA CMI repository (consumer medic · Data as of 2026-10-01、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

Only this ingredient

  • 8,400 mg per mL / per unit basis not statedliquidVELTASSA
  • 16,800 mg per mL / per unit basis not statedliquidVELTASSA

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.